Announcing the 1st #neuroscience phenomap – “Neuromap” – optioned under our collaboration with @Roche and @genentech for $30m. To build it, we produced over 1 trillion hiPSC-derived #neuronal cells – one of the largest such datasets – & scaled new genetic perturbation techniques.
Recursion
3,511 posts
Decoding biology to radically improve lives. The industrial revolution of drug discovery is here.
- Introducing: the largest supercomputer in pharma in the world! The latest @top500supercomp list was just announced and BioHive-2, our new @NVIDIA-powered supercomputer, ranked 35th across all industries. Read the full release here: ir.recursion.com/news-releases/… #techbio $RXRX
00:00 - #BREAKING: We bridged the protein and chemical space by predicting the protein target(s) for ~36 billion compounds in the @EnamineLtd REAL Space using @nvidia’s DGX Cloud and our own NVIDIA-based supercomputer, BioHive-1. Learn more: ir.recursion.com/news-releases/… (1/3)
- Our map-based approach is designed to set the standard for #drugdiscovery in the 21st century. 🎬 In this video, Senior VP of #AI & Digital Sciences @ImranSHaque shares how we use our Mapping & Navigating Technology to explore both known and unknown areas of disease biology to
- Today we announced a collaboration and $50 million investment from @nvidia to accelerate our groundbreaking foundation models in AI-enabled drug discovery. Read the press release: ir.recursion.com/news-releases/… Read the blog from our CTO @bmabey: recursion.com/news/recursion…
- Predicting protein targets for ~36 billion compounds takes a massive team effort. We sat down with our VP of #digitalchemistry @ss_mackinnon to learn more about what went into accomplishing this feat. Read more: recursion.com/news/a-deep-di… #biotech #artificialintelligence
- Meet Dean Li, M.D., Ph.D. — Recursion co-founder & board member, President of @Merck Research Labs. In the first episode of our new #Recursionauts series, Dean shares his perspective on how the convergence of #biology, #computation & #tech is shifting the industry.
00:00 - We are excited to announce that our partner @Roche has exercised the Small Molecule Validation Program Option in a single area of oncology, representing a critical step in our joint efforts to initiate and advance new therapeutic programs. Learn more: bit.ly/3PDsMFE
- It’s been a pleasure having investors and analysts onsite today for Download Day. Thanks to @AndrewE_Dunn at @BusinessInsider for helping us share the latest on all things Recursion. Read the story: bit.ly/404W6ZO #biotech #drugdiscovery #innovation
- Is #Data the New Currency of #Biotech? Vote now for our #SXSW panel to find out! 🗳️ Recursion’s own @TinaMarrLarson, @AAIH’s @PaulHowardNYC & @Valence_ai’s @_DanielCohen are in the running to present on a panel (moderated by @_DimensionCap's @ZavainDar) at #SXSW2024. ☑️ Vote
- #BREAKING: We’re excited to announce we have entered into agreements to acquire @valence_ai and @Cyclica - two leading AI-enabled drug discovery companies - to bolster our chemistry and generative AI capabilities. Learn more: bit.ly/42caoJ5
- #ICYMI - Meet Connie Lee, Founder & CEO of @AllianceToCure Cavernous Malformation. In this episode of our #Recursionauts series, Connie discusses how cerebral cavernous malformation (CCM) affects patients’ daily lives & how we’re partnering to create pathways for the development
- Fueled by 19 petabytes of data and one of the world’s most powerful supercomputers, Recursion is changing how we think about #drugdiscovery. Learn how we’re decoding biology to radically improve lives in our newest Recursion 101 video 👇
00:00 - We're thrilled to see co-founder & #CEO @RecursionChris named to the 2023 Most Influential People in #BioPharma list by @FiercePharma. Read the story to find out how we're using #ML & #AI to revolutionize #drugdiscovery:










